The largest database of trusted experimental protocols
Sourced in United States

FOXO3a is a protein involved in the regulation of gene expression. It is a member of the FOXO family of transcription factors, which play a role in cellular processes such as cell cycle control, apoptosis, and glucose metabolism. FOXO3a acts as a transcriptional regulator and can induce or repress the expression of target genes.

Automatically generated - may contain errors

17 protocols using foxo3a

1

Western Blot Analysis of Tissue Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was performed with the same method used in a previous study [25 (link)]. Cytosolic and nuclear proteins were extracted from the liver, gastrocnemius tissue, and hippocampus with lysis buffers containing protease/phosphatase inhibitor, cytosol-extracting buffer. A total of 30 μg of protein for each group was used for western blot analysis. The extract was separated by 8~12% SDS-PAGE gel electrophoresis then transferred to a polyvinylidene fluoride membrane (Millipore, Billerica, MA, USA). Then, it was incubated overnight with primary antibodies and probed with the respective secondary antibody reagent (Biorad, Hercules, CA, USA). The bands were adjusted by the band levels of α-tubulin (cytosol) or PCNA (nucleus) [25 (link)].
Antibody list: pAkt (sc-81434), Akt (sc-514032), GLUT4 (sc-53566), GLUT2 (sc-518022), FGF21 (sc-81946), KYN (sc-69890), PPARα (sc-398394), FGFR1 (sc-57132), CTSB (sc-365558), PGC1α (sc-517380), Foxo3a (sc-48348), Atroin-1 (sc166806), Murf-1 (sc-398608) (Santa Cruz Biotechnology, CA, USA, 1:200), IRS-1 (#2382), pIRS-1 (#2381), mTOR (#2972), pmTOR (#2971), LC3 (#2775), (#2535), AMPK (#2532) (cell signaling technology, MA, USA, 1:2000), FNDC5 (ab131390), BDNF (ab108319), β-klotho (ab127879) (Abcam, Cambridge, MA, USA, 1:10,000), α-tubulin (T5168, Signa Aldrich, MO, USA, 1:4000), PCNA (610665, Enzolife science, Farmingdale, NY, USA, 1:1000).
+ Open protocol
+ Expand
2

Detecting MAVS Aggregation in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After relevant treatment, cells were washed with cold PBS and lysed in RIPA buffer containing protease and phosphatase inhibitors. Equal amount of protein was subjected to sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis under reducing conditions, proteins transferred to nitrocellulose membrane and subjected to Western blot analysis with antibodies to FOXO3a, MDA5, TLR3, MAVS (Santa Cruz Biotechnology, Santa Cruz, CA), total and phospho-IRF3 (Cell Signaling), or β-actin (Sigma Aldrich, Saint Louis, MO). Specific bands were quantified by densitometry using NIH Image J, and the results expressed as fold change over β-actin or respective total protein. To determine MAVS aggregation, we performed semidenaturing detergent agarose gel electrophoresis (SDD-AGE) under non-reducing conditions as described previously using 1.5% agarose22 (link) with some modifications. Briefly, mitochondrial crude extracts were resuspended in sample buffer (0.5 X TBE containing 10% glycerol, 2% SDS and 0.00025% bromophenol blue) and loaded on horizontal 1.5% agarose gel and the gel was run at 50 volts at 4 °C overnight. The separated proteins were passively transferred to immobilon overnight and subjected to Western blot analysis with an antibody to MAVS.
+ Open protocol
+ Expand
3

Immunohistochemical Evaluation of FoxM1 and FoxO3a

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of FoxM1 and FoxO3a was evaluated by immunohistochemical staining with 4-µm-thick sections from TMA blocks. The sections were first deparaffinized in xylene and then rehydrated through graded ethanol. For antigen retrieval, we performed autoclave heating at 100℃ for 30 min in sodium citrate buffer (pH 6.0). Endogenous peroxidase activity was blocked with peroxidase blocking solution (S2023, DakoCytomation, Carpinteria, CA,USA). TMA slides were incubated with primary antibodies at 4℃ overnight, and then incubated with labeled polymer (DAKO REAL EnVision/HRP, K5007, DakoCytomation) for 30 min at room temperature. The primary antibodies were rabbit anti-human FoxM1 (sc-502; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and FoxO3a (sc-11351; Santa Cruz Biotechnology) polyclonal antibody used in 1:100 dilution. 3,3'-diaminobenzidine was used as a chromogen for detection, and Mayer's hematoxylin counterstain was applied. Immunostaining for ER and HER2 was performed using the Bond-Max automated immunostainer (Leica Biosystems, Wetzlar, Germany) using the following antibodies: anti-ER antibody (Clone 6F11, Novocastra, Newcastle upon Tyne, UK) and anti-HER2 antibody (Clone 10A7, Novocastra).
+ Open protocol
+ Expand
4

Skeletal Muscle and Adipose Tissue Protein Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein extraction of skeletal muscle (gastrocnemius) adipose tissue (epididymis fat) was performed according to a method previously described [36 (link),37 (link)]. Protein was quantified using a BCA Protein Assay Kit (Abcam, Cambridge, MA, USA). The following primary antibodies are used: PGC-1α, pAMPK, AMPK, FoxO3a, Atrogin-1, MuRF1, Bax, Bcl-xL, Akt, pAkt (Santa Cruz Biotechnology, CA, USA, 1:200); S6K1 (Cell Signaling Technology, MA, USA, 1:1000); α-tubulin (Sigma-Aldrich, St. Louis, MO, USA, 1:4000); IGF-1 (Abcam, Cambridge, MA, USA, 1:1000); β-Actin (Bethyl Laboratories, Montgomery, TX, USA, 1:500); PCNA (Enzolife science, Farmingdale, NY, USA, 1:1000).
+ Open protocol
+ Expand
5

Western Blot Analysis of Apoptosis-Related Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed and incubated on ice in RIPA buffer. Protein concentration was detected using BCA kit (Pierce). Protein (30–50 µg) was separated by 6–10% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and transferred onto nitrocellulose (NC) membranes (Bio-Rad Laboratories) followed by incubation with primary antibodies: Bax (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA), Bcl-2 (1:500; Santa Cruz Biotechnology), PI3K (1:500; Santa Cruz Biotechnology), phosphorylation-AKT (p-AKT, 1:500; Santa Cruz Biotechnology), FoxO3a (1:500; Santa Cruz Biotechnology), p53 (1:500; Santa Cruz Biotechnology), p21 (1:500; Santa Cruz Biotechnology) and GAPDH (1:500; Santa Cruz Biotechnology) overnight at 4°C. Protein bands were visualized using anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibodies (1:5,000; Santa Cruz Biotechnology) and by the enhanced chemiluminescence (ECL) reagents (Bio-Rad Laboratories, Hercules, ca, usa). The bands were visualized with the Fusion FX7 system (Vilber Lourmat, Marne la Vallée, France).
+ Open protocol
+ Expand
6

RNA Interference Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-targeting control siRNA and siRNAs against human PARP1, FOXO3A, BRCA1 and BRCA2 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Cells were transfected with each siRNA using Lipofectamine 2000 (Invitrogen, CA) according to the manufacturer's instruction.
+ Open protocol
+ Expand
7

Immunohistochemical Evaluation of FOXO Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of FOXO1, FOXM1, and FOXO3a was evaluated with immunohistochemical staining of 4-µm-thick sections from TMA blocks. The sections were first deparaffinized in xylene and then rehydrated through graded ethanol washes. For antigen retrieval, we performed autoclave heating of the sections at 100℃ for 30 minutes in a sodium citrate buffer (pH 6.0). Endogenous peroxidase activity was blocked with peroxidase blocking solution (S2023; DakoCytomation, Carpinteria, USA). TMA slides were incubated with primary antibodies at 4℃ overnight and incubated with labeled polymer (DAKO REAL EnVision/HRP, K5007; DakoCytomation) for 30 minutes at room temperature. The primary antibodies were rabbit antihuman FOXM1 (sc-502; Santa Cruz Biotechnology, Santa Cruz, USA), FOXO1 (#2880; Cell Signaling, Danvers, USA) and FOXO3a (sc-11351; Santa Cruz Biotechnology) polyclonal antibodies used at a 1:100 dilution. 3,3'-Diaminobenzidine was used as a chromogen for detection, and Mayer's hematoxylin counterstain was applied.
+ Open protocol
+ Expand
8

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were used to extract total proteins using RIPA lysis buffer (Beyotime Institute of Biotechnology) and protein concentration was determined using BCA protein assays (Beyotime Institute of Biotechnology). The proteins (40 µg) from each sample were separated by 10% SDS-PAGE and transferred onto a PVDF membrane (EMD Millipore, Bedford, MA, USA). The membrane was blocked with 5% non-fat milk for 1 h at 37°C and incubated with the following specific primary antibodies: B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax, cat. no. sc-6236; 1:500; Santa Cruz Biotechnology, Inc.), PI3K (cat. no. sc-7174; 1:500; Santa Cruz Biotechnology, Inc.), phosphorylated (p-)AKT (sc-7985-R; 1:300; Santa Cruz Biotechnology, Inc.), FOXO3a (cat. no. 12829; 1:2,000; Cell Signaling Technology, Inc., Danvers, MA, USA) and GAPDH (cat. no. sc-25778; 1:2,000; Santa Cruz Biotechnology, Inc.) at 4°C overnight. Subsequently, the membrane was incubated with corresponding horseradish peroxidase-conjugated secondary antibodies (cat. no. sc-2004; 1:5,000; Santa Cruz Biotechnology, Inc.) at 37°C for 1 h. The blots of the proteins were visualized using Enhanced Chemiluminescence reagents (Beyotime Institute of Biotechnology) and quantified using Image Lab 3.0 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
+ Open protocol
+ Expand
9

Antibody Application and Compound Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary and secondary antibodies applied in this study were introduced as follows: SIRT1, FOXO3a, NRF-1, mTOR, phospho-mTOR, phospho-p70S6 kinase α, NF-κB and p53 antibodies were obtained from Santa Cruz Biotechnology, USA; SIRT6 antibody was purchased from Abcam, UK; β-actin was obtained from Zhongshan Golden Bridge, Beijing, China; Secondary antibodies to mouse and rabbit IgG were purchased from Sigma, USA. SRT1720 was obtained from Selleck, USA, and nicotinamide was obtained from Sigma, USA. They were dissolved in double distilled water containing 10% ethanol and 40% polyethylene glycol 400 for intraperitoneal injection [25 (link)].
+ Open protocol
+ Expand
10

Modulating Apoptosis Pathways in Ovarian Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Akt and FOXO3a were purchased from Millipore; Bim and control small interfering RNA (siRNA) were purchased from Santa Cruz Biotechnology Inc. Human ovarian cancer A2780 and A2780/DDP cells were transfected with Akt, FOXO3a, Bim and control siRNA using Lipofectamine™ 2000, according to the manufacturer's instructions (31 (link)). The cells were then collected and processed for western blot analysis and histone/DNA ELISA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!